Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

3 records in Main database · 3 status checked

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications
Add	OTO-313 by Otonomy	Otonomy	Therapeutic	-	Small Molecule	Phase 2	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	96%	AdultTinnitus+1	Tinnitus
Add	OTO-413 by Otonomy	Otonomy	Therapeutic	-	Biologic	Phase 2	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	95%	AdultNoise-Induced	Hearing LossSensorineural Hearing Loss+2
Add	OTO-825 by Otonomy	Otonomy	Therapeutic	-	Gene Therapy	Preclinical	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	87%	PediatricCongenital+2	Hearing LossSensorineural Hearing Loss+1